
Since the discovery of MHC molecules, it has taken 40 years to arrive at a coherent picture of how MHC class I and MHC class II molecules really work. This is a story of the proteases and MHC-like chaperones that support the MHC class I and II molecules in presenting peptides to the immune system. We now understand that the MHC system shapes both the repertoire of presented peptides and the subsequent T cell response, with important implications ranging from transplant rejection to tumor immunotherapies. Here we present an illustrated review of the ins and outs of MHC class I and MHC class II antigen presentation.
Graft Rejection, Antigen Presentation, T-Lymphocytes, Histocompatibility Antigens Class I, Histocompatibility Antigens Class II, Organ Transplantation, Lymphocyte Activation, Peptide Fragments, Neoplasms, Animals, Humans, Immunotherapy, Antigens, Molecular Chaperones, Peptide Hydrolases
Graft Rejection, Antigen Presentation, T-Lymphocytes, Histocompatibility Antigens Class I, Histocompatibility Antigens Class II, Organ Transplantation, Lymphocyte Activation, Peptide Fragments, Neoplasms, Animals, Humans, Immunotherapy, Antigens, Molecular Chaperones, Peptide Hydrolases
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 653 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 0.1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 0.1% |
